INTRODUCTION {#S0001}
============

Alginate, the monovalent form of alginic acid, belong to the family of linear copolymers composed of β-D- mannuronic acid monomers (M), regions of ∞-L- guluronic acid residues (G), and regions of interspersed M and G units ([@CIT0001]). It is used as matrix material in various formulations due to its hydrogel-forming properties ([@CIT0002]). Alginates undergo gelation due to ionic interaction between carboxylic acid groups located on polymer backbone and these cations like Ca^2+^, Al^3+^, *etc* ([@CIT0003], [@CIT0004]). Various drugs have been successfully incorporated in alginate hydrogels and have exhibited different drug release profiles ([@CIT0001], [@CIT0004]--[@CIT0006]).

Diclofenac sodium (DS) is a non-steroidal anti-inflammatory agent widely used as analgesic ([@CIT0007]). Its biological half-life is 1--2 hr ([@CIT0002]) and requires multiple dosing to maintain therapeutic concentration in blood. Hence, the controlled release systems of DS can eliminate the need for multiple dosing and adverse effects. Several investigations on formulation of DS-loaded alginate-based microparticles/beads using different polymer-blend have been reported ([@CIT0007]--[@CIT0010]). However, no attempt has been taken to formulate DS-loaded bead system using alginate-polyvinyl pyrrolidone (PVP) blend. Therefore in the present investigation, an attempt was made to develope and optimize DS-loaded alginate-PVP K 30 microbeads. The effects of ratios of sodium alginate to PVP K 30 and CaCl~2~ (cross-linker) concentrations on drug entrapment and release were analyzed using central composite design (CCD).

MATERIAL AND METHODS {#S0002}
====================

Materials {#S20003}
---------

DS (Techno Remedies, India), calcium chloride, sodium alginate and PVP K 30 (Loba Chemie, India) were used in this study. Other chemicals used were of analytical grades.

### Microbead preparation

DS-loaded alginate-PVP K 30 microbeads were prepared by ionotropic gelation ([@CIT0002]). Sodium alginate and PVP K 30 aqueous solutions were mixed together. Then, DS was added to the mixture and homogenized (for 10 min, 1000 rpm). The resulting mixture (drug : polymer=1:2) was dropped into CaCl~2~ solution via 26-gauge needle. After 15 min, beads were collected by decantation, washed repeatedly with deionized water and dried at 45°C for 12 hrs.

DS-loaded alginate microbeads were prepared by the same method but without addition of PVP K 30.

### Experimental design

The experimental factors were selected as polymer-blend ratio and CaCl~2~ concentration; while responses were Drug Entrapment Efficiency (DEE) and drug release after 10 hrs (R~10hr~). The factors and levels are reported in [table 1](#T0001){ref-type="table"}. The quadratic model was used to evaluate responses using Design-Expert^®^ Software according to CCD ([@CIT0011]):$$\text{Y} = \text{b}_{0} + \text{b}_{1}\text{X}_{1} + \text{b}_{2}\text{X}_{2} + \text{b}_{3}\text{X}_{1}\text{X}_{2} + \text{b}_{4}\text{X}_{1}^{2} + \text{b}_{5}\text{X}_{2}^{2}$$

###### 

Factors and levels of the circumscribed central composite design

           Experimental Settings   
  -------- ----------------------- -------
  −1.414   1.00                    1.00
  −1       1.50                    2.50
  0        2.80                    6.30
  1        4.00                    10.00
  1.414    4.50                    11.60

a SA:PVP K 30=Sodium alginate to polyvinyl pyrrolidone K 30 ratio

where, Y=response; b~0~=intercept, and b~1~-b~5~=regression coefficients. X~1~ and X~2~=individual effects; X~1~^2^ and X~2~^2^=quadratic effects; X~1~X~2~=interaction effect.

### Determination of the Drug Entrapment Efficiency (DEE)

Drug-loaded microbeads (100 mg) were dispersed in 500 ml of phosphate buffer of pH 7.4 and sonicated for 10 min. The mixture was stirred at 1000 rpm for 4 hrs and filtered through Whatman® filter paper. Drug contents in filtrates were determined using UV-VIS spectrophotometer (Shimadzu, Japan) at 276 nm wavelength. The DEE of beads was calculated using following formula:$$\text{DEE}(\%) = \frac{\text{Actual\ drug\ content}}{\text{Theoretical\ drug\ content}} \times 100$$

### Particle size and morphological analyses

Microbeads were measured for particle size using optical microscope (Olympus, Japan). Surface morphology was examined by scanning electron microscopy (SEM) (Hitachi, Japan).

### Fourier transform infrared (FTIR) spectroscopy

Spectra were obtained by FTIR spectrophotometer (Perkin-Elmer, USA) in the wavelength region of 4000-400 cm^−1^ using pellets of KBr.

### In vitro drug release studies

Dissolution apparatus USP (Campbell Electronics, India) was employed to study the drug release at 37°C 50 rpm. Microbeads containing DS equivalent to 100 mg were taken in 900 ml of dissolution medium (0.1 N HCl of pH 1.2 for 2 hrs and phosphate buffer of pH 7.4 for next hrs). Drug content in samples were measured using UV-VIS spectrophotometer (Shimadzu, Japan) at 276 nm wavelength.

### Swelling evaluation

Microbeads (100 mg) were soaked in phosphate buffer of pH 7.4 and 0.1 N HCl of pH 1.2. Swelled microbeads were removed and weighed. Swelling indexes were determined using the formula:$$\text{Swelling\ index} = \frac{\text{Weight\ of\ swelled\ microbeads\ Dry\ weight}}{\text{Dry\ weight}} \times 100$$

RESULTS AND DISCUSSION {#S0011}
======================

DS-loaded alginate-PVP K 30 microbeads were prepared by ionotropic gelation according to CCD ([Table 2](#T0002){ref-type="table"}). Quadratic models were selected as better-fit models due to smaller PRESS, and insignificant lack of fit ([Table 3](#T0003){ref-type="table"}). Results of ANOVA indicated all models were significant ([Table 4](#T0004){ref-type="table"}). After eliminating non-significant (*p\>*0.05) terms, the models became:$$\text{DEE} = 58.67 - 0.66\text{X}_{1} + 8.12\text{X}_{2} - 1.28\text{X}_{1}^{2} - 0.41\text{X}_{2}^{2}$$ $$\text{R}_{10\text{h}} = 99.43 - 1.13\text{X}_{1} - 3.54\text{X}_{2} - 0.40\text{X}_{1}\text{X}_{2} - 0.06\text{X}_{2}$$

###### 

Experimental plan and observed response values from randomized run in central composite design.

          Normalized levels of factors   Responses[^a^](#TF0001){ref-type="table-fn"}                
  ------- ------------------------------ ---------------------------------------------- ------------ ------------
  SP-1    −1                             −1                                             75.32±2.14   94.44±3.45
  SP-2    −1                             1                                              98.77±2.76   66.32±1.08
  SP-3    1                              −1                                             60.33±1.64   99.56±3.45
  SP-4    1                              1                                              87.87±2.23   78.92±2.40
  SP-5    −1.414                         0                                              94.82±3.42   77.98±2.33
  SP-6    1.414                          0                                              77.68±1.96   92.36±3.02
  SP-7    0                              −1.414                                         58.59±1.12   99.64±3.42
  SP-8    0                              1.414                                          98.88±2.25   67.31±1.88
  SP-9    0                              0                                              89.35±2.16   85.87±2.43
  SP-10   0                              0                                              88.82±2.07   85.07±2.11
  SP-11   0                              0                                              89.20±2.96   85.22±2.40
  SP-12   0                              0                                              90.63±2.88   85.22±2.23
  SP-13   0                              0                                              88.43±2.13   84.95±2.17

Observed response values: Mean±SD (n=3);

SA:PVP K30=Sodium alginate to polyvinyl pyrrolidone K 30 ratio;

DEE=Drug entrapment efficiency (%);

R~10hr~=% Drug released in 10 hrs

###### 

Summary of the model analysis (A), lack of fit (B), and R2 analysis (C) for the measured responses.

  Source                                                    DEE (%)        R~10hr~(%)                                                                                                                                          
  --------------------------------------------------------- -------------- --------------- ---------------------------------------------- --------------- ---------- ---------- ---------------------------------------------- -------
  ([^a^](#TF0005){ref-type="table-fn"}) Model analysis                                                                                                                                                                         
  Mean vs Total                                             92855.36       93597.19                                                                                                                                            
  Linear vs Mean                                            1771.28        \< 0.0001       1296.88                                        \< 0.0001                                                                            
  2FIc vs Linear                                            4.18           0.7105          13.99                                          0.0028                                                                               
  Quadratic vs 2FI                                          241.45         \< 0.0001       4.57                                           0.0395                                                                               
  Cubic vs Quadratic                                        4.82           0.3780          2.01                                           0.0635                                                                               
  Residual                                                  10.14          1.00                                                                                                                                                
  Total                                                     94887.24       94915.63                                                                                                                                            
                                                                                                                                                                                                                               
  ([^b^](#TF0006){ref-type="table-fn"}) Lack of fit                                                                                                                                                                            
  Linear                                                    257.83         0.0007          21.04                                          0.0034                                                                               
  2FI                                                       253.65         0.0005          7.05                                           0.0195                                                                               
  Quadratic                                                 12.20          0.0600          2.49                                           0.0533                                                                               
  Cubic                                                     7.37           0.0310          0.48                                           0.1293                                                                               
  Pure error                                                2.77           0.52                                                                                                                                                
                                                                                                                                                                                                                               
                                                                                                                                                                                                                               
  **([^c^](#TF0007){ref-type="table-fn"}) R^2^ analysis**   **Adjusted**   **Predicted**   **Adjusted**                                   **Predicted**                                                                        
                                                                                                                                                                                                                               
  **R^2^**                                                  **R^2^**       **R^2^**        **PRESS[^d^](#TF0008){ref-type="table-fn"}**   **R^2^**        **R^2^**   **R^2^**   **PRESS[^d^](#TF0008){ref-type="table-fn"}**   
                                                                                                                                                                                                                               
  Linear                                                    0.8717         0.8461          0.7762                                         454.69          0.9836     0.9804     0.9651                                         45.98
  2FI                                                       0.8738         0.8317          0.6734                                         663.68          0.9943     0.9923     0.9860                                         18.52
  Quadratic                                                 0.9926         0.9874          0.9552                                         91.05           0.9977     0.9961     0.9860                                         18.49
  Cubic                                                     0.9950         0.9880          0.7656                                         476.18          0.9992     0.9982     0.9763                                         31.24

DEE=Drug entrapment efficiency(%);

R10hr =% Drug released in 10 hrs;

2FI=Two factor interaction;

PRESS=predicted residual sum of squares.

###### 

Summary of ANOVA for the response parameters

  Source                     Sum of squares   Degree of freedom   Mean square   *F*value   *p*-value Prob\>*F*
  -------------------------- ---------------- ------------------- ------------- ---------- ---------------------
  \(A\) For DEE (%)a                                                                       
                                                                                           
  Model                      2016.91          5                   403.38        188.70     \< 0.0001
  X~1~                       314.12           1                   314.12        146.94     \< 0.0001
  X~2~                       1457.15          1                   1457.15       681.64     \< 0.0001
  X~1~X~2~                   4.18             1                   4.18          1.96       0.2046
  X~1~^2^                    27.77            1                   27.77         12.99      0.0087
  X~2~^2^                    230.44           1                   230.44        107.80     \< 0.0001
                                                                                           
                                                                                           
  \(B\) For R~10hr~ (%)^b^                                                                 
                                                                                           
  Model                      1315.43          5                   263.09        612.17     \< 0.0001
  X~1~                       181.04           1                   181.04        421.25     \< 0.0001
  X~2~                       1115.84          1                   1115.84       2596.44    \<0.0001
  X~1~X~2~                   13.99            1                   13.99         32.55      0.0007
  X~1~^2^                    0.02             1                   0.02          0.05       0.8376
  X~2~^2^                    4.3              1                   4.39          10.22      0.0151

DEE=Drug entrapment efficiency (%); R~10hr~=% Drug released in 10 hrs.

X~1~ and X~2~ represent the factors; X~1~ ^2^ and X~2~ ^2^ are the quadratic effect; X~1~X~2~ is the interaction effect.

Three-dimensional response surface ([Fig. 1](#F0001){ref-type="fig"}), and contour plots ([Fig. 2](#F0002){ref-type="fig"}) demonstrate changes in DEE, and R~10hr~ due to variation of factors. For optimization, numerical analysis was performed by restricting desirable ranges to 95 ≤ DEE ≤ 100%, and 60 ≤ R~10hr~ ≤ 65%. The optimized microbeads were formulated and evaluated ([Table 5](#T0005){ref-type="table"}). Models to produce optimized responses were well fitted (R^2^=0.9912 for DEE, and 0.9967 for R~10hr~).

![Effects of experimental factors presented by response surface plots (a, b).](DARU-19-356-g001){#F0001}

![Effect of main effects on responses presented by contour plots (a, and b).](DARU-19-356-g002){#F0002}

###### 

Results of experiments for confirmation of the optimization capability.

        Factors   Responses                                
  ----- --------- ----------- ------- ------------ ------- ------------
  O-1   1.00      8.60        99.45   98.27±3.42   69.55   71.28±2.22
  O-2   1.50      9.20        99.79   98.60±3.55   69.41   71.02±2.67
  O-1   2.20      10.30       99.16   97.88±2.86   68.46   69.88±2.82

SA:PVP K 30=Sodium alginate to polyvinyl pyrrolidone K 30 ratio;

DEE=Drug entrapment efficiency (%);

R10hr=% Drug released within 10 hrs;

Observed response values: Mean±SD (n=3).

Optimized microbeads showed DEE of 97.88±2.86 to 98.60±3.55%. Among DS-loaded alginate microbeads, highest DEE of 85.77±2.92% was observed in the case of S-3 ([Table 6](#T0006){ref-type="table"}).

###### 

Processing parameters and responses of plain alginate microbeads containing diclofenac sodium.

        Processing parameters   Responses[^a^](#TF0013){ref-type="table-fn"}                
  ----- ----------------------- ---------------------------------------------- ------------ ------------
  S-1   2.00                    8.60                                           78.23±2.06   95.38±3.62
  S-2   2.00                    9.20                                           81.48±3.15   91.22±3.23
  S-1   2.00                    10.30                                          85.77±2.92   81.03±3.05

Observed response values: Mean±SD (n=3);

SA=Sodium alginate;

DEE=Drug entrapment efficiency (%);

R10hr =% Drug released in 10 hrs

The particle sizes of alginate-PVP K 30 microbeads decreased by increase in the amount of incorporated PVP K 30 (due to decrease in viscosity and droplet sizes of polymer solution), and the CaCl~2~ concentration (due to high degree cross-linking) ([Table 7](#T0007){ref-type="table"}). The surface morphology of optimized beads was visualized by SEM, which showed rough surface ([Fig. 3](#F0003){ref-type="fig"}).

![Photomicrograph of the surface morphology of DS-loaded alginate-PVP K 30 microbead (O-2).](DARU-19-356-g003){#F0003}

###### 

Average diameter of alginate-PVP K 30 and plain alginate microbeads containing diclofenac sodium, measured by optical microscopic method.

  Formulation codes[^a^](#TF0017){ref-type="table-fn"}   Average diameter (mm)[^b^](#TF0018){ref-type="table-fn"}
  ------------------------------------------------------ ----------------------------------------------------------
  SP-1                                                   0.93±0.08
  SP-2                                                   0.59±0.07
  SP-3                                                   0.95±0.10
  SP-4                                                   0.84±0.07
  SP-5                                                   0.79±0.05
  SP-6                                                   0.87±0.09
  SP-7                                                   0.97±0.07
  SP-8                                                   0.60±0.06
  SP-9                                                   0.86±0.08
  SP-10                                                  0.86±0.10
  SP-11                                                  0.86±0.08
  SP-12                                                  0.84±0.06
  SP-13                                                  0.85±0.09
  O-1                                                    0.59±0.05
  O-2                                                    0.62±0.08
  O-3                                                    0.62±0.07
  S-1                                                    0.87±0.07
  S-2                                                    0.83±0.08
  S-3                                                    0.82±0.08

SP-1 to O-3 were alginate-PVP K 30 microbeads; whereas S-1-S-3 were plain alginate microbeads containing diclofenac sodium.

Mean±SD (n=3)

In FTIR spectra, incorporation of DS in alginate showed characteristic peaks of DS, and alginate ([Fig. 4](#F0004){ref-type="fig"}). However, in DS-loaded alginate-PVP K 30 microbeads, two characteristic shifts for C=O stretching of PVP, and --OH groups of alginate compared to pure component ([Fig. 4](#F0004){ref-type="fig"}) appeared which strongly supports the idea of an intermolecular hydrogen-bonding between C=O groups of PVP, and --OH groups of alginate in alginate-PVP K 30 microbeads.

![FTIR spectra of DS, sodium alginate, PVP K 30, DS-loaded alginate (S-3) and DS-loaded alginate-PVP K 30 microbeads (O-2).](DARU-19-356-g004){#F0004}

Microbeads were found to release negligible amounts of DS in acidic medium which probably could be the surface adhered drug. Alginate-PVP K 30 microbeads showed prolonged drug release over 10 hrs ([Figs. 5](#F0005){ref-type="fig"} and [6](#T0006){ref-type="table"}). In contrast, alginate microbeads showed high percent of DS release ([Fig. 6](#F0006){ref-type="fig"}). The drug release from optimized microbeads was evaluated using various kinetic models, and it was found that the drug release followed zero-order model ([Table 8](#T0008){ref-type="table"}), indicating controlled-release pattern. The Korsmeyer-Peppas model was employed to distinguish Fickian-release when n ≤0.43 and case-II transport when n ≥0.85 (in Korsmeyer-Peppas Model, n is diffusional exponent) ([@CIT0012], [@CIT0013]). The values of n ranged between 0.9632 to 0.9950 ([Table 8](#T0008){ref-type="table"}), indicating the drug release followed case-II transport.

![(a). In vitro drug release from alginate-PVP K 30 microbeads containing DS (SP-1 to SP-6) (Mean±SD, n=3). (b). In vitro drug release from alginate-PVP K30 microbeads containing DS (SP-7 to SP-13) (Mean±SD, n=3)](DARU-19-356-g005){#F0005}

![In vitro drug release from optimized alginate-PVP K 30 microbeads (O-1 to O-3) and alginate microbeads (S-1 to S-3) containing DS (Mean±SD, n=3).](DARU-19-356-g006){#F0006}

###### 

Results of curve fitting of the *in-vitro* diclofenac sodium release data from different optimized alginate-PVP K30 microbeads.

  Formulation codes            O-1      O-2      O-3
  ------------------- -------- -------- -------- --------
  Zero-order Model    K~o~     0.0711   0.0705   0.0730
  R~2~                0.9962   0.9937   0.9960   
                                                 
  First-order Model   K~1st~   0.1426   0.1394   0.1427
                      R~2~     0.9795   0.9736   0.9602
                                                 
  Higuchi Model       K~H~     0.3486   0.3456   0.3579
  R~2~                0.9870   0.9825   0.9845   
                                                 
  Korsmeyer-Peppas    K~P~     0.0779   0.0724   0.0728
                                                 
  Model               n        0.9632   0.9884   0.9950
  R~2~                0.9955   0.9871   0.9952   

The swelling of optimized DS-loaded alginate-PVP K 30 microbeads was lower in acidic medium (pH 1.2) in comparison with that of alkaline medium (pH 7.4) ([Fig. 7](#F0007){ref-type="fig"}). Maximum swelling was noticed after 2--3 hrs in alkaline pH after which, erosion and dissolution took place. The swelling of optimized microbeads in alkaline pH could be explained by the exchange of ions between the calcium ion of microbeads and the sodium ions present in phosphate buffer, under influence of calcium-sequestrant phosphate ions, which could result in disaggregation of alginate-PVP K 30-matrix structure leading to matrix erosion and dissolution of swollen microbeads ([@CIT0014], [@CIT0015]).

![Swelling behavior of the optimized alginate-PVP K 30 microbeads containing DS in pH 1.2 and pH 7.4. (Mean±SD, n=3).](DARU-19-356-g007){#F0007}

CONCLUSION {#S0012}
==========

The optimized formulation of alginate-PVP K 30 microbeads containing DS was developed based on central composite design. The DEE of optimized alginate-PVP K 30 microbeads containing DS were found to be 97.88±2.86 to 98.60±3.55 % with a controlled-release pattern (zero-order) and case-II transport drug release. The swelling behaviour of the developed microbeads was influenced by the pH of the test medium. The FTIR spectroscopy showed an intermolecular hydrogen-bonding which could be formed between C=O groups of PVP K 30 and --OH groups of alginate in alginate-PVP K 30 microbeads which might sustaine drug release from alginate-PVP K 30 microbeads and minimize drug leaching during preparation to facilitate increase in DEE. The methods of preparation of DS-loaded alginate-PVP K 30 for controlled release characteristics were found to be simple and reproducible. In conclusion, an oral alginate-PVP K 30 microbeads for controlled delivery system of DS was successfully developed by alginate-PVP K 30 blending using ionotropic gelation.
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